{"prompt": "['A. Pro-inflammatory', 'B.', 'Transcription', 'C.', 'Cellular origin', 'genes', 'factors', '1.10-', '4.0-', 'MAPS down-regulated', 'MAPS up-regulated', 'p', '10.0 7.5 5.0 2.5', '0', 'D-score', '0', '2.5 5.0 7.5 10.0', 'p', '1.05', '2.0-', '.0038', 'Monocytes', '.5798', '1.0', '.0001', 'Dendritic cells', '5761', '1.00', '.7824', 'NK cells', '.8949', '0.95', '.50-', '9988', 'CD4+ T cells', '.3086', '.9993', 'CD8+ T cells', '.8729', '0.90', '-.25-', '2276', 'B cells', '.0001', 'In summary, the results from this phase II randomized pilot study support the short term effects of', 'mindfulness meditation in younger breast cancer survivors on reduction of perceived stress and', 'depressive symptoms, with the suggestion that this intervention may also have beneficial effects on', 'inflammatory processes, with potential relevance for behavioral and disease-related outcomes. In', 'addition, there were favorable effects on common behavioral symptoms, including fatigue, perceived', 'sleep quality, and vasomotor symptoms. Thus this intervention appears quite promising. In addition,', 'women who received the mindfulness intervention had sustained improvement in intrusive thoughts', 'and reduced fear of recurrence as measured at 3 months post-intervention,', '3.4 Survivorship Education (SE) Intervention Program', 'For the survivorship education intervention, we have adapted materials from several other studies that have', 'provided survivorship education to women with breast cancer including a study of younger women with', 'breast cancer37 as well as those used in a previous evaluation of women with post-treatment fatigue, who', 'received this intervention in comparison to an Iyengar yoga intervention, which was found to improve', 'depressive', 'symptoms. 38 Similarly, the intervention education programs used in the Scheier study described', 'in', 'the', 'background', 'section', '12 and in the Moving Beyond Cancer study39 demonstrated benefit to women', 'enrolled in those trials. The Johns Hopkins team also has considerable experience in the delivery of', 'survivorship education to this target population. The expertise of the three clinical sites has been used to', 'refine the survivorship education curriculum and slide set so it can be delivered systematically by each of', 'the participating research sites. The full lecture series has been developed and is ready for pilot-testing prior', 'to implementation across the three sites.', '3.5', 'Rationale and Significance of the Planned Study', 'Younger women with breast cancer account for one quarter of the newly-diagnosed breast cancer cases each', 'year, and close to one million of the 3 million breast cancer survivors. The largest gains in survival from', 'multi-modal treatments have occurred in this age group. Although younger women with breast cancer can', 'expect long survival times after diagnosis and treatment, they also face an extended period of time living', 'with the risk for breast cancer recurrence, as well as long term and late effects of cancer treatments.', 'Research has documented higher levels of depression, anxiety, stress and other symptoms in these younger', 'women. Many are also in a stressful period in their lives, completing their education, establishing intimate', 'partnerships, having children or raising a family, as well as working and caring for elderly parents. Finding', 'effective behavioral or educational strategies to help younger breast cancer patients heal and maintain good', 'physical', 'and', 'mental', 'health during the post-treatment period is a high priority for post-treatment survivorship', 'care. The development and evaluation of interventions that hold promise for this population of breast cancer', 'patients is a cancer control priority given their unique needs and long life expectancy. In this study we will', 'focus on breast cancer survivors who were diagnosed at 50 years of age or younger, because they are', 'particularly at risk for greater depressive symptoms, as supported in the literature. In addition, eligibility', 'Revised Protocol June 22, 2020', 'Page 13 of 50']['inclusion will focus on younger women who are manifesting evidence of increased depressive symptoms,', 'so that we are targeting those most likely to benefit from the interventions being tested.', 'The interventions that will be tested in this research have face and content validity, a history of use in other', 'populations, and preliminary efficacy in younger breast cancer survivors with psychological and physical', 'symptoms. The intervention programs are already developed with proven preliminary efficacy in related', 'populations and the clinical coordinating center and selected research sites have a track record conducting', 'studies similar to these. The testing of these two interventions in a phase III RCT setting in multiple sites', 'will establish the feasibility of the intervention delivery in settings that have not used them before, determine', 'the short term efficacy of the two interventions compared to the control condition, and the correlative', 'science study will enhance our understanding of potential mechanisms for the efficacy of the intervention(s)', 'if one or both are deemed effective.', '4.', 'PARTICIPANT SELECTION', '4.1', 'Inclusion Criteria', '4.1.1', 'Women diagnosed with early stage, resectable breast cancer (Stage 0, I, II, or III) at 50 years or younger,', 'and are within 5 years of diagnosis', '4.1.2', 'Have completed all surgery, radiation, and/or chemotherapy treatments at least 6 months previously.', 'May still be receiving trastuzumab or endocrine adjuvant therapy.', '4.1.3 Ability to complete evaluation surveys in English.', '4.1.4 Have evidence of at least mild clinical depression on a standardized screening questionnaire (i.e., score', 'of 5 of greater, later revised to score of 3 or greater, on PHQ-8; implemented May 6, 2019 for cohort', '5).', '4.2', 'Exclusion Criteria', '4.2.1 Has a breast cancer recurrence, metastasis, or another interval cancer diagnosis following the breast', 'cancer (excluding non-melanoma skin cancer);', '4.2.2 Unable to commit to intervention schedule (6 weekly group meetings)', '4.2.3', 'Actively practicing mindfulness meditation', '4.2.4 Has another serious or chronic medical or psychiatric condition that contributes to substantial physical', 'or emotional disability that would detract from participating in either of the intervention programs or', 'from the measurement of intervention outcomes.', '4.2.5', 'Is currently pregnant', '4.3', 'Inclusion of Underrepresented Populations', 'Individuals of all races and ethnic groups are eligible for this trial. There is no bias towards race in the', 'clinical trial outlined, and special efforts will be made to encourage participation of women of diverse', 'racial/ethnic groups. This trial is open to the accrual of women only because there are so few men who', 'develop breast cancer at a young age, and for scientific reasons this study is focused on younger women.', 'Revised Protocol June 22, 2020', 'Page 14 of 50']\n\n###\n\n", "completion": "END"}